Readcrest Capital AG Increases Consolidated Revenue and Earnings in the First Half of 2026 - Sale of Care Home Business Significantly Strengthens Balance Sheet

Readcrest Capital's H1 2026 revenue rose 1.6% to EUR 65.3 million, while net income increased to EUR 24.9 million from EUR 0.4 million, primarily reflecting a EUR 29.4 million gain on the sale of its U.K. care-home business. The disposal generated EUR 44.3 million of cash proceeds, helping reduce net financial liabilities by EUR 56.6 million to EUR 123.5 million and doubling cash to EUR 20.3 million. Post-period acquisitions expanded U.K. home-care operations, while a majority stake in RC Industrie Immobilien SE established a new German light-industrial real-estate division.

Analysis

The key investable change is balance-sheet optionality rather than recurring earnings power. Asset-sale proceeds and debt retirement reduce refinancing risk, but the reported profit is non-recurring and should not support a higher steady-state earnings multiple; valuation should instead be anchored to normalized home-care EBITDA, residual property NAV, and the cost of funding future acquisitions. The remaining leverage is still material relative to a business mix that now combines regulated UK care services with early-stage German real-estate exposure.

Near term, EXJ0 could re-rate if management discloses acquired-care-business revenue, EBITDA margins, organic hours growth, and post-deal leverage at the November investor events. The principal 1-3 month risk is that local-authority rate increases merely offset wage inflation, leaving care margins flat despite revenue growth; UK labor shortages and minimum-wage policy are the relevant leading indicators. Over 6-18 months, the addition of light-industrial real estate may create NAV upside, but it also risks recreating development-cycle complexity and capital demands before the existing projects generate cash.

Contrarian view: the market may initially capitalize the headline EPS uplift, while the more likely institutional debate is whether management has exchanged a tangible asset for a lower-margin, acquisition-dependent care platform plus illiquid property optionality. A durable re-rating requires evidence that debt reduction is not followed by renewed leverage for property development or further acquisitions at elevated multiples. With no disclosed market capitalization, normalized EBITDA, acquisition consideration, or liquidity data, there is insufficient basis to underwrite a target price or options structure.

Key Decisions for Investors

• Maintain EXJ0 as a watchlist/hold rather than add on the initial result: require disclosure of pro forma net debt/EBITDA, acquired-business EBITDA, and organic care margin at the November 11-23 investor events before sizing a position.
• Consider a small long EXJ0 only after confirmation that recurring care EBITDA and free cash flow cover interest expense with headroom; risk/reward improves if the stock has not already priced in the one-off gain. Exit or avoid if management guides to debt-funded development spending before recurring cash generation.
• Set a downside alert for evidence that UK wage inflation exceeds local-authority fee increases for two consecutive reporting periods; this would falsify the margin-expansion case and likely drive multiple compression.
• Monitor transaction terms for RC Industrie Immobilien SE and the three care acquisitions. Any meaningful equity issuance, related-party structure, or leverage increase would shift the thesis from deleveraging re-rating to governance and balance-sheet risk.